Alkotinib Capsules
ZGALK002
Phase 2 small_molecule terminated
Quick answer
Alkotinib Capsules for ALK-positive Non-small Cell Lung Cancer is a Phase 2 program (small_molecule) at Suzhou Zelgen Biopharmaceuticals Co.,Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Indication
- ALK-positive Non-small Cell Lung Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated